Description
+ Include: 13 videos + 12 pdfs, size: 4.86 GB
+ Target Audience: cardiologist, internist, family medicine physician
+ Sample video: contact me for sample video
+ Information:
Friday, October 1, 2021, 7:45 AM – 2:00 PM EST, Live, Virtual, Philadelphia, PA
Cardiovascular disease is the leading cause of death in the United States. Hypertension and diabetes are among the foremost risk factors for the development of cardiovascular diseases, including stroke, peripheral artery disease, and heart attack. Several advances have been made in recent years to improve our ability to prevent the development and progression of cardiovascular disease. This program will provide an overview of recent advances that target the underlying pathophysiology of cardiovascular disease. The focus of the program will be on the use of SGLT 2 Inhibitors and GLP-1 agonists to reduce the risk of cardiovascular disease and progression of kidney disease, monitoring and management of hypertension in special patient populations, and common lipid issues in patient care.
- Select appropriate medications to reduce adverse cardiovascular outcomes in high-risk and vulnerable populations
- Identify appropriate blood pressure goals and management in several special patient populations
- Describe the controversies regarding the appropriate screening, confirmatory testing, and management of patients at risk for primary aldosteronism
- Achieve competence in providing the best screening and treatment options for hypertension in patients with hyperlipidemia
- Apply appropriate pharmacologic and non-pharmacologic approaches to cardiovascular risk prevention
+ Topics:
Antiplatelet Treatment – Who Needs it..mp4
Antiplatelet Treatment – Who Needs it..pdf
Brochure_71943.docx
Case Discussion with the Experts.mp4
Cholesterol Management During Pregnancy When to Check, and How to Manage..mp4
Cholesterol Management During Pregnancy When to Check, and How to Manage..pdf
Efficacy and Outcome Studies for Renal Disease in DM and non DM.mp4
Efficacy and Outcome Studies for Renal Disease in DM and non DM.pdf
Efficacy and Outcomes Studies for CV Protection.mp4
Efficacy and Outcomes Studies for CV Protection.pdf
How to Prescribe SGLT2 Inhibitors – The Practicalities.mp4
How to Prescribe SGLT2 Inhibitors – The Practicalities.pdf
Introduction and Welcome.mp4
Lp(a). – What Should I Know..mp4
Lp(a). – What Should I Know..pdf
Management of Hypertension in CKD.mp4
Management of Hypertension in CKD.pdf
Management of Hypertension in the Hospital Setting.mp4
Management of Hypertension in the Hospital Setting.pdf
New Opportunities to Integrate Home BP into Telehealth.mp4
New Opportunities to Integrate Home BP into Telehealth.pdf
Noninvasive Evaluation of CAD What Test Should I Order..mp4
Noninvasive Evaluation of CAD What Test Should I Order..pdf
Primary Aldosteronism – A Continuum From Normotension to Resistant Hypertension.mp4
Primary Aldosteronism – A Continuum From Normotension to Resistant Hypertension.pdf
Reviews
There are no reviews yet.